TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer-Reference-Cited by-同舟云学术

TC2N, a novel oncogene, accelerates tumor progression by suppressing p53 signaling pathway in lung cancer

Published:2018-09-25 Issue:7 Volume:26 Page:1235-1250
ISSN:1350-9047
Container-title:Cell Death & Differentiation
language:en
Short-container-title:Cell Death Differ

Author:

Hao Xiang-lin^ORCID,Han Fei,Zhang Ning,Chen Hong-qiang,Jiang Xiao,Yin Li,Liu Wen-bin,Wang Dan-dan,Chen Jian-ping,Cui Zhi-hong,Ao Lin,Cao Jia,Liu Jin-yi^ORCID

Funder

National Natural Science Foundation of China

Publisher

Springer Science and Business Media LLC

Subject

Cell Biology,Molecular Biology

Link

http://www.nature.com/articles/s41418-018-0202-8.pdf

Reference50 articles.

1. Torre LA1, Bray F, Siegel RL, Ferlay J, Lortet-Tieulent J, Jemal A. Global cancer statistics, 2012. CA Cancer J Clin. 2015;65:87–108.

2. Yuan S, Yu Z, Liu Q, Zhang M, Xiang Y, Wu N, et al. GPC5, a novel epigenetically silenced tumor suppressor, inhibits tumor growth by suppressing Wnt/beta-catenin signaling in lung adenocarcinoma. Oncogene. 2016;35:6120–31.

3. Neri S, Yoshida J, Ishii G, Matsumura Y, Aokage K, Hishida T, et al. Prognostic impact of microscopic vessel invasion and visceral pleural invasion in non-small cell lung cancer: a retrospective analysis of 2657 patients. Ann Surg. 2014;260:383–8.

4. Zhang J, Gold KA, Lin HY, Swisher SG, Xing Y, Lee JJ, et al. Relationship between tumor size and survival in non-small-cell lung cancer (NSCLC): an analysis of the surveillance, epidemiology, and end results (SEER) registry. J Thorac Oncol. 2015;10:682–90.

5. Wanders R, Steevens J, Botterweck A, Dingemans AM, Reymen B, Av Baardwijk, et al. Treatment with curative intent of stage III non-small cell lung cancer patients of 75 years: a prospective population-based study. Eur J Cancer. 2011;47:2691–2197.

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A novel hsa_circ_0006903 circular RNA promotes tumor development and dendritic cells activated expression in infantile hemangioma;Heliyon;2024-07

2. IDMIR: identification of dysregulated miRNAs associated with disease based on a miRNA–miRNA interaction network constructed through gene expression data;Briefings in Bioinformatics;2024-05-23

3. Identification of a new HLA-A*0201-restricted cytotoxic T lymphocyte epitope from TC2N;European Journal of Microbiology and Immunology;2024-02-23

4. TC2N inhibits distant metastasis and stemness of breast cancer via blocking fatty acid synthesis;Journal of Translational Medicine;2024-01-02

5. Exploring the anticancer potential of Eleutherine bulbosa: A systematic network pharmacology study on lung cancer;Journal of Advanced Pharmaceutical Technology & Research;2024-01